VIRGINIA RETIREMENT SYSTEMS ET AlVIRGINIA RETIREMENT SYSTEMS ET Al

Institutional investor · Portfolio as of Q1 2022

SEC EDGAR SourceSEC Filings

Top Holdings1,108 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

APPLE INC

3.3M$571.3M5.3%$93.05+87.20%
19 qtrssince 2017-Q3
Increased
62

MICROSOFT CORP

1.6M$507.3M4.7%$100.77+201.99%
19 qtrssince 2017-Q3
Increased
59

ALPHABET INC-CL A

75,000$208.6M2.0%$56.52+149.26%
19 qtrssince 2017-Q3
Increased
50

AMAZON.COM INC

63,300$206.4M1.9%$69.30+139.96%
19 qtrssince 2017-Q3
Unchanged
0

ALPHABET INC-CL C

64,838$181.1M1.7%$52.45+169.93%
19 qtrssince 2017-Q3
Increased
49

BERKSHIRE HATHAWAY INC-CL B

454,600$160.4M1.5%$198.93+79.77%
19 qtrssince 2017-Q3
Decreased
0

COSTCO WHOLESALE CORP

238,100$137.1M1.3%$320.91+71.29%
19 qtrssince 2017-Q3
Increased
58

TESLA INC

126,700$136.5M1.3%$203.28+79.39%
8 qtrssince 2020-Q2
Increased
55
PLDPLD
REIT

PROLOGIS INC

835,401$134.9M1.3%$64.75+125.93%
19 qtrssince 2017-Q3
Increased
51

JOHNSON & JOHNSON

676,532$119.9M1.1%$106.22+51.35%
19 qtrssince 2017-Q3
Increased
48

ACCENTURE PLC-CL A

346,300$116.8M1.1%$138.54+130.81%
19 qtrssince 2017-Q3
Decreased
0
PSAPSA
REIT

PUBLIC STORAGE

298,054$116.3M1.1%$246.91+33.72%
19 qtrssince 2017-Q3
Increased
71

NVIDIA CORP

414,100$113M1.1%$16.17+70.98%
19 qtrssince 2017-Q3
Unchanged
0

UNITEDHEALTH GROUP INC

216,280$110.3M1.0%$261.16+86.95%
19 qtrssince 2017-Q3
Unchanged
0

BRISTOL-MYERS SQUIBB CO

1.4M$104.9M1.0%$42.63+46.42%
19 qtrssince 2017-Q3
Decreased
0

VERIZON COMMUNICATIONS INC

2M$101.7M1.0%$33.74+17.88%
19 qtrssince 2017-Q3
Increased
42

META PLATFORMS INC-CLASS A

449,000$99.8M0.9%$173.91+30.11%
19 qtrssince 2017-Q3
Unchanged
0

PFIZER INC

1.8M$95.5M0.9%$32.08+31.89%
19 qtrssince 2017-Q3
Increased
59

MERCK & CO. INC.

1.1M$93.6M0.9%$60.58+21.34%
19 qtrssince 2017-Q3
Increased
43

ARCHER-DANIELS-MIDLAND CO

1M$91.3M0.9%$34.01+133.44%
19 qtrssince 2017-Q3
Decreased
0
$10.7B
AUM
1,108
Positions
Q1 2022
Filing
Rating · 1.5
Quarterly Portfolio Change
+9%Q4'20$9.5B+7%Q1'21$10.2B-1%Q2'21$10.2B-4%Q3'21$9.8B+50%Q4'21$14.7B-27%Q1'22$10.7B
Activity profile
$ moved · Q1'22
New5%Increased29%Decreased56%Exited9%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.0 years
<1Q6%1-4Q10%1-2Y11%2Y+73%

VIRGINIA RETIREMENT SYSTEMS ET Al manages $10.7B across 1108 positions as of Q1 2022. Top holdings: AAPL (5.3%), MSFT (4.7%), GOOGL (2.0%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.

Q1 2022 Summary

Active quarter - 173 new positions, 162 exits, 416 increased. Top move: PSA (INCREASED, conviction 71). Portfolio: $10.7B across 1108 positions.

Top holdings by portfolio weight

Total AUM$11B
AAPL5.35%
MSFT4.75%
GOOGL1.95%
AMZN1.93%
GOOG1.70%
BRK/B1.50%
COST1.28%
TSLA1.28%
PLD1.26%
JNJ1.12%
Other1.09%

Portfolio allocation by GICS sector

Sectors11
Technology21.49%
Financial Services13.66%
Healthcare11.65%
Real Estate10.67%
Consumer Cyclical8.72%
Communication Services8.21%
Consumer Defensive7.23%
Industrials6.31%
Utilities3.87%
Unknown3.85%
Other4.34%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Financial Services, Healthcare
Compare DNA across all funds
7-dimension quality assessment

Last filed Q4 2025 - no longer filing.

Below Average(1.5 / 5.0)
Track RecordNo data
Conviction41
Concentration0
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
PECOPECOPHILLIPS EDISON & COMPANY IN
Q1 2025 Q4 2025+37,738 shares+$1.4M
4Q
WELLWELLWELLTOWER INC
Q1 2025 Q4 2025+261,400 shares+$61.8M
4Q
BCRXBCRXBIOCRYST PHARMACEUTICALS INC
Q1 2025 Q4 2025+186,254 shares+$1.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used